Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Classical hematology 1

Conditions

Neoplasms 2Thromboembolism 1Thrombocytopenia 1Sarcoma 1Postoperative Hemorrhage 1Ovarian Neoplasms 1Menorrhagia 1Leiomyoma 1Hemostatic Disorders 1Hemorrhage 1Hematologic Neoplasms 1Breast Neoplasms 1Bone Neoplasms 1Blood Loss, Surgical 1

Interventions

Gemcitabine 57Paclitaxel 50Cyclophosphamide 45pembrolizumab 44Carboplatin 41Bevacizumab 38Cisplatin 33Docetaxel 31Fluorouracil 30Nivolumab 29Capecitabine 29Pemetrexed 24Irinotecan 24Oxaliplatin 23Dexamethasone 23Ipilimumab 22Leucovorin 21Radiotherapy 20Sorafenib 19Doxorubicin 19Everolimus 18Cetuximab 18fludarabine 17Albumin-Bound Paclitaxel 17trametinib 15Sunitinib 15Rituximab 15Erlotinib Hydrochloride 15130-nm albumin-bound paclitaxel 15Prednisone 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Neoplasms × Tranexamic Acid × Clear all
NCT01980355 2023-08-07

TXA

Corewell Health West

Phase NA Completed
76 enrolled 9 charts
Tumor-Agnostic

Neoplasms

NCT03806556 2021-09-20

A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia

University of Pittsburgh

Phase 1/2 Terminated
11 enrolled 15 charts
Classical hematology

Neoplasms, Thrombocytopenia, Hemostatic Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡